Striatal dopamine sensitization to D-amphetamine in periadolescent but notin adult rats

Citation
G. Laviola et al., Striatal dopamine sensitization to D-amphetamine in periadolescent but notin adult rats, PHARM BIO B, 68(1), 2001, pp. 115-124
Citations number
60
Categorie Soggetti
Neurosciences & Behavoir
Journal title
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
ISSN journal
00913057 → ACNP
Volume
68
Issue
1
Year of publication
2001
Pages
115 - 124
Database
ISI
SICI code
0091-3057(200101)68:1<115:SDSTDI>2.0.ZU;2-P
Abstract
The neurobiological and behavioral facets of adolescence have been poorly i nvestigated in relation to the vulnerability to psychostimulants. Periadole scent (33-43 days) and adult (> 70 days) Sprague-Dawley rats underwent a 3- day treatment history with D-amphetamine (AMPH) at 0, 2, or 10 mg/kg (once a day). After a short 5-day-long withdrawal interval, freely moving animals were challenged with a 2-mg/kg AMPH dose and their behavior as well as in vivo intrastriatum dopamine (DA) release in the CNS were assessed. Microdia lysis data indicated that AMPH-history periadolescent rats showed a promine nt sensitization of AMPH-stimulated DA release, whereas no such change was found in adult subjects. As expected, acute AMPH administration strongly re duced time spent lying still and increased levels of cage exploration in an imals of both ages. A treatment history of high AMPH dosage was associated with a marked sensitization of the exploratory behavior in adults, whereas it induced a quite opposite profile in periadolescents. The latter group on ly was also characterized by a compulsive involvement in the stereotyped he ad-bobbing response. These results indicate that differently from adults, m arked alterations in neurobiological target mechanisms are observed in rats around periadolescence as a consequence of a quite mild regimen of intermi ttent AMPH exposure. Thus, a neurobiological substrate for an age-related i ncreased vulnerability towards the addictive risks of these drugs is sugges ted. (C) 2001 Elsevier Science Inc. All rights reserved.